FIG 2.
Unbound cefepime plasma concentrations from trough samples in the third, sixth, and ninth dosing intervals in patients with neutropenic fever and hematological malignancy receiving 2-g i.v. q8h dosing.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.